キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/05/23 | 3,865 | 3,890 | 3,840 | 3,855 | -10 | -0.3% | 69,200 |
2025/05/22 | 3,850 | 3,885 | 3,840 | 3,865 | -25 | -0.6% | 55,800 |
2025/05/21 | 3,885 | 3,920 | 3,850 | 3,890 | +5 | +0.1% | 62,200 |
2025/05/20 | 3,930 | 3,935 | 3,870 | 3,885 | -10 | -0.3% | 65,400 |
2025/05/19 | 3,835 | 3,915 | 3,815 | 3,895 | +90 | +2.4% | 97,500 |
2025/05/16 | 3,820 | 3,860 | 3,770 | 3,805 | +20 | +0.5% | 93,400 |
2025/05/15 | 3,780 | 3,820 | 3,760 | 3,785 | +5 | +0.1% | 69,900 |
2025/05/14 | 3,905 | 3,960 | 3,750 | 3,780 | -160 | -4.1% | 114,400 |
2025/05/13 | 4,040 | 4,045 | 3,920 | 3,940 | -85 | -2.1% | 154,300 |
2025/05/12 | 4,110 | 4,135 | 3,925 | 4,025 | -130 | -3.1% | 161,100 |
2025/05/09 | 3,940 | 4,215 | 3,930 | 4,155 | +180 | +4.5% | 227,500 |
2025/05/08 | 4,200 | 4,200 | 3,880 | 3,975 | +165 | +4.3% | 659,300 |
2025/05/07 | 3,795 | 3,835 | 3,750 | 3,810 | +15 | +0.4% | 115,200 |
2025/05/02 | 3,795 | 3,830 | 3,775 | 3,795 | ±0 | ±0% | 75,200 |
2025/05/01 | 3,770 | 3,795 | 3,750 | 3,795 | +50 | +1.3% | 61,300 |
2025/04/30 | 3,750 | 3,755 | 3,705 | 3,745 | +45 | +1.2% | 76,800 |
2025/04/28 | 3,715 | 3,745 | 3,690 | 3,700 | -25 | -0.7% | 66,500 |
2025/04/25 | 3,780 | 3,795 | 3,720 | 3,725 | -50 | -1.3% | 38,900 |
2025/04/24 | 3,850 | 3,895 | 3,775 | 3,775 | -70 | -1.8% | 67,700 |
2025/04/23 | 3,850 | 3,860 | 3,815 | 3,845 | +10 | +0.3% | 58,200 |
2025/04/22 | 3,790 | 3,890 | 3,785 | 3,835 | +55 | +1.5% | 77,000 |
2025/04/21 | 3,730 | 3,795 | 3,715 | 3,780 | +70 | +1.9% | 58,800 |
2025/04/18 | 3,650 | 3,740 | 3,615 | 3,710 | +115 | +3.2% | 73,000 |
2025/04/17 | 3,580 | 3,600 | 3,560 | 3,595 | +15 | +0.4% | 47,600 |
2025/04/16 | 3,635 | 3,645 | 3,560 | 3,580 | -55 | -1.5% | 71,700 |
2025/04/15 | 3,650 | 3,670 | 3,630 | 3,635 | ±0 | ±0% | 38,900 |
2025/04/14 | 3,600 | 3,675 | 3,590 | 3,635 | +95 | +2.7% | 68,900 |
2025/04/11 | 3,540 | 3,550 | 3,480 | 3,540 | -135 | -3.7% | 86,000 |
2025/04/10 | 3,660 | 3,695 | 3,630 | 3,675 | +85 | +2.4% | 130,400 |
2025/04/09 | 3,595 | 3,680 | 3,560 | 3,590 | -60 | -1.6% | 107,600 |
2025/04/08 | 3,690 | 3,690 | 3,575 | 3,650 | +30 | +0.8% | 118,800 |
2025/04/07 | 3,505 | 3,715 | 3,505 | 3,620 | -95 | -2.6% | 194,300 |
2025/04/04 | 3,835 | 3,835 | 3,705 | 3,715 | -50 | -1.3% | 156,200 |
2025/04/03 | 3,645 | 3,800 | 3,630 | 3,765 | -5 | -0.1% | 101,300 |
2025/04/02 | 3,805 | 3,810 | 3,740 | 3,770 | -45 | -1.2% | 66,600 |
2025/04/01 | 3,865 | 3,865 | 3,805 | 3,815 | -30 | -0.8% | 63,300 |
2025/03/31 | 3,845 | 3,880 | 3,755 | 3,845 | -45 | -1.2% | 99,000 |
2025/03/28 | 3,930 | 3,940 | 3,875 | 3,890 | -45 | -1.1% | 88,900 |
2025/03/27 | 3,880 | 3,940 | 3,875 | 3,935 | +30 | +0.8% | 125,900 |
2025/03/26 | 3,865 | 3,910 | 3,855 | 3,905 | +25 | +0.6% | 78,300 |
2025/03/25 | 3,865 | 3,890 | 3,805 | 3,880 | +15 | +0.4% | 61,600 |
2025/03/24 | 3,840 | 3,880 | 3,825 | 3,865 | +40 | +1% | 53,200 |
2025/03/21 | 3,800 | 3,840 | 3,800 | 3,825 | -20 | -0.5% | 55,200 |
2025/03/19 | 3,755 | 3,860 | 3,755 | 3,845 | +20 | +0.5% | 83,700 |
2025/03/18 | 3,825 | 3,870 | 3,800 | 3,825 | +10 | +0.3% | 76,800 |
2025/03/17 | 3,750 | 3,815 | 3,695 | 3,815 | +50 | +1.3% | 60,200 |
2025/03/14 | 3,730 | 3,785 | 3,730 | 3,765 | ±0 | ±0% | 58,100 |
2025/03/13 | 3,710 | 3,800 | 3,705 | 3,765 | +65 | +1.8% | 69,300 |
2025/03/12 | 3,555 | 3,715 | 3,555 | 3,700 | +80 | +2.2% | 76,600 |
2025/03/11 | 3,640 | 3,660 | 3,565 | 3,620 | -45 | -1.2% | 93,600 |
1~
50
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 385,500円 | +3.6% | +6.1% | 3.11% | 12.99倍 | 0.76倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サワイGHD | 188,900円 | +5.9% | +24.5% | 2.91% | 12.53倍 | 1.18倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
ペプチド | 167,300円 | +5.0% | +1.5% | 0.00% | 14.31倍 | 3.81倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
科研薬 | 373,800円 | -6.4% | -71.8% | 5.08% | 41.63倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム